The media frequently report on the high costs of the various health-related treatments. Since there is a limit to the resources available for public and private health insurance, they are not able to provide any new treatments available. This raises the question of how to determine which treatments should be offered under a health plan. Cost-benefit analysis has emerged as a powerful tool to determine priorities and guide these decisions. This note is intended as a background for a reading … Read more »

The media frequently report on the high costs of the various health-related treatments. Since there is a limit to the resources available for public and private health insurance, they are not able to provide any new treatments available. This raises the question of how to determine which treatments should be offered under a health plan. Cost-benefit analysis has emerged as a powerful tool to determine priorities and guide these decisions. This note is intended as background for reading a first class on pharmacoeconomics and cost-benefit analysis.
«Hide

from
Gregory S. Zaric
4 pages.
Release Date: 08 July, 2010. Prod #: 910E07-PDF-ENG
The agony of choice – An Introduction to cost-benefit analysis HBR case solution